HRT Contraindications: When Hormone Therapy Is Really Off the Table and When It's a Myth

A doctor listening to a patient during a consultation about hormone therapy and its contraindications
By
Tatiana Bakounine
Published
November 11, 2026

“I can't take hormones” is one of the most common things women say about menopause, and it is often wrong. The real list of HRT contraindications is much shorter than most people think. For many other situations, the honest answer isn't “never.” It's “not ‘no’, but ‘let's do the maths’”: weigh your personal risk in numbers against what therapy could give you.

This guide explains which conditions actually rule out menopausal hormone therapy (HRT, also called MHT), which ones only call for a closer look, and how to turn a vague fear into a clear conversation with your doctor. It is not a recommendation to start or stop anything. It's a map, so you know which questions to ask.

What “contraindication” really means

In medicine, an absolute contraindication means a treatment shouldn't be used because the risk clearly outweighs any possible benefit. A relative contraindication, or simply a risk factor, means the treatment may still be possible, but it needs a careful assessment, the right type and route of therapy, and closer monitoring.

Much of the confusion around HRT comes from mixing these two categories. A family history, a fibroid or a breast lump that turned out to be benign are often treated as a flat “no,” when in current guidelines they are reasons to assess, calculate and monitor, not automatic bans.

Absolute HRT contraindications: the short list

The situations where systemic hormone therapy is genuinely off the table are few:

  • Breast cancer, now or in the past.
  • Thrombosis: a history of blood clots in the veins.
  • A previous heart attack or stroke.
  • Active liver disease.
  • Unexplained vaginal bleeding, until the cause has been found.

Everything else falls into the “let's do the maths” zone. That doesn't mean everything else is automatically safe. It means the decision depends on your personal numbers, not on a general rule passed on by a friend or found in an old leaflet.

Myth 1: “My mother had breast cancer, so HRT is off limits”

This is probably the most common fear, and it's understandable. A family history of breast cancer does raise a woman's own risk. But in current guidelines a family history on its own is not a contraindication to HRT.

What matters is the detail: who in the family was affected, at what age, and how many relatives. A mother diagnosed at 75 is a different story from two close relatives diagnosed in their 40s. In some situations it makes sense to see a geneticist first, before any decision about therapy.

So the useful question isn't “Did anyone in my family have breast cancer?” but “What exactly happened, to whom and when, and what does that mean for my risk?”

HRT and breast cancer risk: what the numbers say

To talk about risk honestly, you need numbers rather than adjectives. One of the largest analyses on this question, published in The Lancet in 2019, pooled data on more than 108,000 women with breast cancer.

For five years of therapy started at age 50, the extra risk looked like this:

  • Estrogen plus a daily progestogen: about 1 additional case of breast cancer per 50 women.
  • Estrogen plus an intermittent progestogen: about 1 additional case per 70 women.
  • Estrogen alone: about 1 additional case per 200 women.

Two more points from the same analysis matter. The risk grew with the duration of therapy. And local vaginal estrogens, used in small amounts for dryness and urinary symptoms, were not linked to an excess risk.

Why do some women take estrogen with a progestogen and others estrogen alone? As a general rule, women who still have a uterus need a progestogen alongside estrogen to protect the lining of the womb. Women without a uterus usually don't. That is one reason the type of therapy, and therefore the risk profile, varies from person to person.

The short version: “This is not ‘safe’. It's measurable.” And a measurable risk is something you can weigh against measurable benefits.

Myth 2: “I have fibroids, so I can't take hormones”

Uterine fibroids are benign growths that depend on estrogen. That is why they usually shrink after menopause, when estrogen levels fall. On hormone therapy, a fibroid may grow slightly.

That is a reason for monitoring, not a ban. In practice, it means a pelvic ultrasound to keep an eye on size and paying attention to any bleeding. A known fibroid is a factor in choosing and following up therapy, not an automatic “no.”

Myth 3: “There's a lump in my breast, so HRT is out”

Any new breast lump needs to be investigated first, before any decision about therapy: a mammogram, an ultrasound and, if needed, a biopsy. This order matters.

If the lump is confirmed to be benign, it is not a contraindication to HRT. It does mean regular breast monitoring while you are on therapy. The ban applies to breast cancer, not to every lump.

Myth 4: “It's been more than 10 years since menopause, so it's too late”

Here there is a real nuance. According to the 2022 position statement of the North American Menopause Society (NAMS, now The Menopause Society), starting systemic hormone therapy more than 10 years after menopause, or after age 60, gives a less favourable balance of benefits and risks. The absolute risks of coronary heart disease, stroke, blood clots and dementia are higher in this group.

Timing matters, but “less favourable” is not the same as “there is nothing you can do.” Some options remain on the table even then:

  • Local (vaginal) therapy for dryness, discomfort and recurrent cystitis.
  • Other ways to support bones, muscles and sleep, chosen with your doctor. If bone health is your main concern, read how to protect your bones in menopause.

If hot flashes are the main problem and systemic HRT isn't right for you, there are also non-hormonal treatments for hot flashes worth discussing.

Myth 5: “Hormones are dangerous, full stop”

Hormone therapy is a medical treatment. Like any treatment, it has benefits, risks and situations where it isn't appropriate. Calling it simply “dangerous” or simply “safe” hides the information you actually need: how big the risk is for you, and what it is being weighed against.

For women whose symptoms disrupt sleep, work and relationships, that comparison often looks very different from the general fear. The old idea that you should just put up with it doesn't hold up either. We cover that in why “our grandmothers managed without HRT” is bad advice.

How to prepare for the HRT conversation with your doctor

The most useful thing you can bring to an appointment isn't an opinion, but information. Before your visit:

  • Write down your own history: blood clots, heart or liver problems, breast findings and how they were investigated, fibroids, any unusual bleeding.
  • Write down your family history: which relatives had which conditions, and at what age.
  • Note when your last period was, so the timing question can be answered precisely.
  • List the symptoms that bother you most and how they affect your life.

And ask one question directly: “What is my risk in numbers, and what does it outweigh?” A good answer will include both sides of the scale.

Frequently asked questions

What are the absolute contraindications to HRT?

Breast cancer now or in the past, a history of thrombosis, a previous heart attack or stroke, active liver disease and unexplained vaginal bleeding. Most other situations require an individual assessment rather than an automatic ban.

Can I take HRT if my mother had breast cancer?

A family history of breast cancer raises your own risk, but in current guidelines it is not a contraindication on its own. What matters is who was affected, at what age and how many relatives. Sometimes a consultation with a geneticist comes first.

How much does HRT increase breast cancer risk?

According to a 2019 Lancet analysis, five years of therapy started at 50 meant about 1 additional case per 50 women on estrogen plus a daily progestogen, 1 per 70 with an intermittent progestogen and 1 per 200 on estrogen alone. The risk grew with duration. Local vaginal estrogens were not linked to excess risk.

Can you take HRT with fibroids?

Fibroids are not an automatic ban. They depend on estrogen and may grow slightly on therapy, so doctors usually monitor them with ultrasound and pay attention to bleeding.

Is it too late to start HRT after 60?

According to the 2022 NAMS position statement, starting systemic therapy after 60 or more than 10 years after menopause gives a less favourable balance, with higher absolute risks of heart disease, stroke, blood clots and dementia. Local vaginal therapy and other ways to support bones, muscles and sleep remain options to discuss with your doctor.

The bottom line

The list of real HRT contraindications is short. For almost everything else, the right approach is not fear and not blind confidence, but numbers: your history, your family history, your timing and your symptoms, weighed honestly with a doctor.

If you want hormones, biomarkers, sleep and stress looked at together rather than one at a time, that is what the Personalised Method is built for.

Want a clear plan instead of conflicting advice? Apply for a Strategic Session.

Sources

  • Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 2019. pubmed.ncbi.nlm.nih.gov/31474332
  • The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022. pubmed.ncbi.nlm.nih.gov/35797481
  • NICE guideline NG23. Menopause: identification and management. nice.org.uk/guidance/ng23
  • Educational background: Women's Health and Wellness Program, Harvard Medical School Executive Education.

This article is for educational purposes only and does not replace medical advice. Any decision about hormone therapy is made individually, with your doctor.

Tatiana Bakounine
Private Health & Longevity Advisor

Apply for a Strategic Session

A short application. I will reply personally within 1–2 working days.